Nia Therapeutics, Inc. — SEC Form D Filing

Nia Therapeutics, Inc. filed an SEC Form D on March 6, 2026, reporting $18.84M raised in Health Care.

Form D filing details

Filing
SEC Form D
Filing date
March 6, 2026
Amount reported
$18.84M
Round stage
Seed
Industry
Health Care
Website
https://niatherapeutics.com/

What the company does

Securities: Equity. Exemption: Rule 506(b). Incorporated: DELAWARE

Problem

Nia Therapeutics addresses the issue of memory loss affecting 27 million Americans through innovative treatments.

Solution

They provide closed-loop brain stimulation technology to enhance memory and cognitive function.

Why now

With an increasing number of individuals experiencing cognitive disorders, there is a timely need for innovative treatment solutions.

Verdict

Investors supported Nia Therapeutics because the narrative around brain-computer interface solutions for memory loss was timely, not because traditional treatments yielded high confidence in efficacy. This cleared because the increasing prevalence of cognitive disorders provided a convincing market signal, not because there was a proven demand for Nia’s specific technology. Implicitly, investors bet on a rapidly evolving sector, but the limited upside comes from potential regulatory hurdles and a lack of established adoption in clinical settings.

Source: SEC EDGAR Form D filing